Unbiased identification of substrates for the Epac1-inducible E3 ubiquitin ligase component SOCS-3

Biochemical Society Transactions

Volumn 40, Issue 1, 2012, Pages 215-218

  Williams, Jamie J L ^a   Palmer, Timothy M ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cytokine; Exchange protein directly activated by cAMP (Epac); Janus kinase (JAK); Signal transducer and activator of transcription (STAT); Suppressor of cytokine signalling (SOCS); Ubiquitin ligase

Indexed keywords

CYCLIC AMP; CYTOKINE; EXCHANGE PROTEIN DIRECTLY ACTIVATED BY CAMP 1; PROTEIN TYROSINE PHOSPHATASE; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; REVIEW; UBIQUITINATION;

ANIMALS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; PROTEIN STRUCTURE, TERTIARY; PROTEIN SUBUNITS; SUBSTRATE SPECIFICITY; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATED PROTEINS; UBIQUITINATION;

EID: 84863073767     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20110629     Document Type: Review

References (31)

1. Heinrich, P.C., Behrmann, I., Haan, S., Hermanns, H.M., Muller-Newen, G. and Schaper, F. (2003) Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374, 1-20 (Pubitemid 37046923)
2. O'Shea, J.J. and Murray, P.J. (2008) Cytokine signaling modules in inflammatory responses. Immunity 28, 477-487 (Pubitemid 351467044)
3. Grivennikov, S.I., Greten, F.R. and Karin, M. (2010) Immunity, inflammation, and cancer. Cell 140, 883-899
4. Rose-John, S., Waetzig, G.H., Scheller, J., Grötzinger, J. and Seegert, D. (2007) The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin. Ther. Targets 11, 613-624 (Pubitemid 46730080)
5. Tonks, N.K. (2006) Protein tyrosine phosphatases: from genes, to function, to disease. Nat. Rev. Mol. Cell Biol. 7, 833-846
6. Rytinki, M.M., Kaikkonen, S., Pehkonen, P., Jaaskelainen, T. and Palvimo, J.J. (2009) PIAS proteins: pleiotropic interactors associated with SUMO. Cell. Mol. Life Sci. 66, 3029-3041
7. Palvimo, J.J. (2007) PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription. Biochem. Soc. Trans. 35, 1405-1408
8. Yoshimura, A., Naka, T. and Kubo, M. (2007) SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7, 454-465 (Pubitemid 46834848)
9. Johnston, J.A. (2004) SOCS: role in inflammation, allergy and homeostasis. J. Leukocyte Biol. 75, 743-748
10. Sands, W.A., Woolson, H.D., Milne, G.R., Rutherford, C. and Palmer, T.M. (2006) Exchange protein activated by cyclic AMP (Epac)-mediated induction of suppressor of cytokine signaling 3 (SOCS-3) in vascular endothelial cells. Mol. Cell. Biol. 26, 6333-6346 (Pubitemid 44277875)
11. Yarwood, S.J., Borland, G., Sands, W.A. and Palmer, T.M. (2008) Identification of CCAAT/enhancer-binding proteins as exchange protein activated by cAMP-activated transcription factors that mediate the induction of the SOCS-3 gene. J. Biol. Chem. 283, 6843-6853
12. Croker, B.A., Krebs, D.L., Zhang, J.G., Wormald, S., Willson, T.A., Stanley, E.G., Robb, L., Greenhalgh, C.J., Förster, I., Clausen, B.E. et al. (2003) SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 4, 540-545 (Pubitemid 36701336)
13. Lang, R., Pauleau, A.L., Parganas, E., Takahashi, Y., Mages, J., Ihle, J.N., Rutschman, R. and Murray, P.J. (2003) SOCS3 regulates the plasticity of gp130 signaling. Nat. Immunol. 4, 546-550 (Pubitemid 36701337)
14. Sasaki, A., Yasukawa, H., Suzuki, A., Kamizono, S., Syoda, T., Kinjyo, I., Sasaki, M., Johnston, J.A. and Yoshimura, A. (1999) Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells 4, 339-351 (Pubitemid 29359449)
15. Fukada, T., Hibi, M., Yamanaka, Y., Takahashi-Tezuka, M., Fujitani, Y., Yamaguchi, T., Nakajima, K. and Hirano, T. (1996) Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity 5, 449-460 (Pubitemid 26423473)
16. Kamura, T., Sato, S., Haque, D., Liu, L., Kaelin, Jr, W.G., Conaway, R.C. and Conaway, J.W. (1998) The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev. 12, 3872-3881 (Pubitemid 29024849)
17. Piessevaux, J., Lavens, D., Peelman, F. and Tavernier, J. (2008) The many faces of the SOCS box. Cytokine Growth Factor Rev. 19, 371-381
18. Zhang, J.G., Farley, A., Nicholson, S.E., Willson, T.A., Zugaro, L.M., Simpson, R.J., Moritz, R.L., Cary, D., Richardson, R., Hausmann, G. et al. (1999) The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc. Natl. Acad. Sci. U.S.A. 96, 2071-2076
19. Boyle, K., Egan, P., Rakar, S., Willson, T.A., Wicks, I.P., Metcalf, D., Hilton, D.J., Nicola, N.A., Alexander, W.S., Roberts, A.W. and Robb, L. (2007) The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo. Blood 110, 1466-1474 (Pubitemid 47443961)
20. Boyle, K., Zhang, J.G., Nicholson, S.E., Trounson, E., Babon, J.J., McManus, E.J., Nicola, N.A. and Robb, L. (2009) Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation. Cell. Signalling 21, 394-404
21. Liu, E., Côté, J.F. and Vuori, K. (2003) Negative regulation of FAK signaling by SOCS proteins. EMBO J. 22, 5036-5046 (Pubitemid 37222024)
22. Niwa, Y., Kanda, H., Shikauchi, Y., Saiura, A., Matsubara, K., Kitagawa, T., Yamamoto, J., Kubo, T. and Yoshikawa, H. (2005) Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma. Oncogene 24, 6406-6417 (Pubitemid 41486474)
23. Orr, S.J., Morgan, N.M., Elliott, J., Burrows, J.F., Scott, C.J., McVicar, D.W. and Johnston, J.A. (2007) CD33 responses are blocked by SOCS3 through accelerated proteasomal-mediated turnover. Blood 109, 1061-1068 (Pubitemid 46220652)
24. Orr, S.J., Morgan, N.M., Buick, R.J., Boyd, C.R., Elliott, J., Burrows, J.F., Jefferies, C.A., Crocker, P.R. and Johnston, J.A. (2007) SOCS3 targets Siglec 7 for proteasomal degradation and blocks Siglec 7-mediated responses. J. Biol. Chem. 282, 3418-3422 (Pubitemid 47084418)
25. Tanaka, Y., Tanaka, N., Saeki, Y., Tanaka, K., Murakami, M., Hirano, T., Ishii, N. and Sugamura, K. (2008) c-Cbl-dependent monoubiquitination and lysosomal degradation of gp130. Mol. Cell. Biol. 28, 4805-4818
26. Nalepa, G., Rolfe, M. and Harper, J.W. (2006) Drug discovery in the ubiquitin-proteasome system. Nat. Rev. Drug Discovery 5, 596-613
27. Westman, B.J., Verheggen, C., Hutten, S., Lam, Y.W., Bertrand, E. and Lamond, A.I. (2010) A proteomic screen for nucleolar SUMO targets shows SUMOylation modulates the function of Nop5/Nop58. Mol. Cell 39, 618-631
28. Westman, B.J. and Lamond, A.I. (2011) A role for SUMOylation in snoRNP biogenesis revealed by quantitative proteomics. Nucleus 2, 30-37
29. Hör, S., Ziv, T., Admon, A. and Lehner, P.J. (2009) Stable isotope labeling by amino acids in cell culture and differential plasma membrane proteome quantitation identify new substrates for the MARCH9 transmembrane E3 ligase. Mol. Cell. Proteomics 8, 1959-1971
30. Meierhofer, D., Wang, X., Huang, L. and Kaiser, P. (2008) Quantitative analysis of global ubiquitination in HeLa cells by mass spectrometry. Proteome Res. 7, 4566-4576
31. Houslay, M.D. (2010) Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown. Trends Biochem. Sci. 35, 91-100